|Articles|May 11, 2012

Study Supports Soy Isoflavones and Cocoa Flavonoids for Type 2 Diabetes

Compared to placebo, cocoa and soy supplementation improved insulin and cholesterol markers in type 2 diabetic women.

In a one-year study, type 2 diabetics experienced improved heart health biomarkers when assigned to daily consumption of cocoa flavonoids and soy isoflavones.

U.K. researchers assigned 93 postmenopausal women with type 2 diabetes to a daily combination of two highly standardized ingredients: SoyLife from Frutarom Ltd. (Haifa, Israel) featuring 100 mg of soy isoflavones and Acticoa from Barry Callebaut (Zurich, Switzerland) featuring 850 mg of flavan-3-ols.

Compared to placebo, the cocoa and soy supplementation improved insulin resistance, decreased insulin levels, improved ratios of total cholesterol to HDL cholesterol, and reduced LDL cholesterol levels in subjects.

Both Frutarom and Barry Callebaut supported the study, now published in the journal Diabetes Care.


Related to this article

Omega-3 Supply, Not Price, Is the Real Threat
With Peru's anchovy fishery opening its 2026 season with its lowest quota in a decade, Matts Johansen argues that aquaculture's growing appetite for omega-3s, not just El Niño, is what should actually be keeping supplement brands up at night.
Powerful Plants
Emerging plant protein sources are redefining how protein products are formulated.